Abstract
AIM: Angiogenesis plays a central role in the growth of a tumor. The hypoxiainducible factor 1α (HIF-1α) is a regulated subunit of HIF-1, a key factor that carries fundamental features in angiogenesis and tumor progression. Renal cell carcinoma (RCC) is highly vascularized with a variable clinical outcome, having specific genetic alterations in different RCC types. This study investigated HIF-1α mRNA and protein expression in relation to RCC type and clinicopathological variables including clinical stage and survival. METHODS: Quantitative analysis of HIF-1α mRNA expression in 202 patients including 168 clear cell (cRCC), 23 papillary (pRCC) and 11 chromophobe RCCs. Additionally, 49 samples from non-malignant corresponding kidney cortex were analysed. Comparative analysis of HIF-1α protein expression was performed by immunohistochemistry of tissue microarray. RESULTS: HIF-1α mRNA levels were significantly lower in cRCC compared with pRCC (P = 0.001) and kidney cortex (P < 0.001). In cRCC, HIF-1α mRNA was correlated to gender and age. For pRCC there was no correlation between HIF-1α mRNA and tumor stage, nuclear grade, age, tumor size or gender. HIF-1α mRNA expression was inversely related to HIF-1α protein levels in pRCC (P = 0.041) but not significantly in cRCC (P = 0.075). CONCLUSION: HIF-1α mRNA levels were significantly lower in cRCC copmpared with kidney cortex and the other RCC types. High HIF-1α protein expression appeared to suppress HIF-1α mRNA expression, distressing the HIF-1 pathway in RCC.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.